Basit öğe kaydını göster

dc.contributor.authorBedir, Recep
dc.contributor.authorŞehitoğlu, İbrahim
dc.contributor.authorYurdakul, Cüneyt
dc.contributor.authorMurtezaoğlu, Ain R.
dc.contributor.authorÜstüner, Pelin
dc.date.accessioned2020-12-19T19:50:30Z
dc.date.available2020-12-19T19:50:30Z
dc.date.issued2016
dc.identifier.citationBedir, R., İbrahim, Ş., Yurdakul, C., Mürtezaoğlu, A. R., & Üstüner, P. (2016). Chondroid syringomas: an immunohistopatological analysis. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 151(4), 358–364.en_US
dc.identifier.issn0392-0488
dc.identifier.issn1827-1820
dc.identifier.urihttps://hdl.handle.net/11436/2438
dc.descriptionWOS: 000384950300006en_US
dc.descriptionPubMed: 25922159en_US
dc.description.abstractBACKGROUND: Chondroid syringoma is a rare benign skin adnexal tumor composed of both epithelial and mesenchymal components, and is known as a cutaneous mixed tumor. Its clinical diagnosis is generally incorrect, and an exact diagnosis can only be made with histopathological investigations. the aim of this study was to determine the clinicopathological findings of the cases diagnosed with chondroid syringoma. METHODS: in this study, over the period from January 2008 to March 2014, a total of 2661 excised skin lesions were evaluated for the clinicopathological findings, and fifteen cases were diagnosed with chondroid syringoma. Various parameters such as gender, mean age, tumor localization and immunohistochemical markers (pan-cytokeratin, vimentin, S-100 protein, CEA-(M) and p53 were examined. RESULTS: of the 15 cases diagnosed with chondroid syringoma, 10 (67%) were male and 5 (33%) were female. the mean age of the patients was 46 (range 11-80 years). the chondroid syringomas were positive for pan-cytokeratin (87%), vimentin (100%), S-100 protein (100%), CEA-M (53%) and p53 (80%). CONLUSIONS: Chondroid syringomas should be included in the differential diagnosis of a slowly growing, nodular mass in the dermis. Definitive diagnosis of the tumor is made by histopathological examination. Difficult cases may benefit from immunohistochemical examination.en_US
dc.language.isoengen_US
dc.publisherEdizioni Minerva Medicaen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdenomaen_US
dc.subjectPleomorphicen_US
dc.subjectImmunohistochemistryen_US
dc.subjectSkinen_US
dc.titleChondroid syringomas: an immunohistopatological analysisen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorBedir, Recep
dc.contributor.institutionauthorŞehitoğlu, İbrahim
dc.contributor.institutionauthorYurdakul, Cüneyt
dc.contributor.institutionauthorMurtezaoğlu, Ain R.
dc.identifier.volume151en_US
dc.identifier.issue4en_US
dc.identifier.startpage358en_US
dc.identifier.endpage364en_US
dc.relation.journalGiornale Italiano Di Dermatologia E Venereologiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster